Oak Bracket

Metadata

Regulatory Status

Europe

• Not listed in any European pharmacopoeia or herbal medicine monograph.
• No traditional medicinal use is well-documented for this species specifically, though oak-associated polypores have been used in European folk medicine generally.
• Known primarily as a tree pathogen: Forestry literature focuses on its role as a destructive white rot pathogen of oaks. It causes extensive basal decay and is a significant concern for arborists and foresters.

United States

• Not marketed as a dietary supplement or food product.
• No GRAS determination. Not evaluated by the FDA for any purpose.
• Forestry significance: Recognized as one of the most important basal rot fungi of oaks in North America.

China, Japan, Korea

• Not listed in the Chinese Pharmacopoeia, Japanese Pharmacopoeia, or Korean Pharmacopoeia.
• No documented traditional medicinal use in East Asian herbal medicine systems, unlike its relative Inonotus obliquus (chaga) and Phellinus linteus (meshima).

Conditions & Indications

Primary: Antioxidant Activity (Preclinical Evidence)

• Free radical scavenging: The whole extract and isolated cerevisterol from I. dryadeus fruiting bodies demonstrated free radical scavenging activity comparable to the positive control quercetin in DPPH and superoxide anion model systems.
• Styrylpyrone antioxidant pigments: Chemical analysis has identified hispidin and related styrylpyrone compounds in I. dryadeus. Hispidin is one of the most potent natural antioxidants identified from fungi, with activity demonstrated across multiple Inonotus and Phellinus species.

Secondary: Antimicrobial Activity (Preclinical Evidence)

• Antibacterial potential: Early-stage reports suggest that extracts from I. dryadeus demonstrate antibacterial activity against certain gram-positive and gram-negative bacteria in vitro. However, detailed characterization of the active compounds and spectrum of activity is lacking. [NEEDS-RESEARCH]

Emerging/Preclinical

• Hispidin-class pharmacology (inferred): Based on the confirmed presence of hispidin and related styrylpyrones, I. dryadeus may share some of the pharmacological activities demonstrated for hispidin in other species, including antioxidant, anti-inflammatory, antitumor, antiviral, and antidiabetic effects. However, these activities have not been directly demonstrated for I. dryadeus extracts or compounds. [UNCERTAIN]
• Polysaccharide content: Polysaccharides have been detected in I. dryadeus, consistent with the immunomodulatory polysaccharide profiles of other Hymenochaetaceae. Bioactivity of these polysaccharides has not been specifically assessed. [NEEDS-RESEARCH]
• Relationship to chaga pharmacology: As a congener of Inonotus obliquus (chaga), I. dryadeus shares biosynthetic pathways for styrylpyrones and triterpenoids. Whether the specific compound profiles and concentrations are comparable remains to be determined.

Mechanism of Action

Primary Mechanisms

1. Styrylpyrone antioxidant chemistry: Hispidin and related styrylpyrone pigments are the signature bioactive class of the Hymenochaetaceae. These compounds contain catechol moieties that donate hydrogen atoms to free radicals, directly neutralizing reactive oxygen species. Hispidin has been shown to inhibit lipid peroxidation, scavenge DPPH, superoxide, and hydroxyl radicals, and chelate transition metals that catalyze oxidative damage. In I. dryadeus, hispidin, bisnoryangonin, phellinins A1/A2, and several bis(styrylpyrones) have been identified, suggesting a robust antioxidant chemical arsenal.

2. Cerevisterol-mediated cytoprotection: Cerevisterol, isolated from the fruiting body, activates the Nrf2/HO-1 antioxidant signaling cascade and suppresses NF-kB-mediated inflammatory signaling. This steroid is shared with numerous other medicinal fungi and provides a well-characterized anti-inflammatory and cytoprotective mechanism.

3. Lipid-based bioactivity: The complex mixture of free fatty acids, sphingosine derivatives, and diacylglycerophospholipids isolated from I. dryadeus may contribute to antimicrobial and membrane-modulating activity, though specific mechanisms have not been elucidated for this species. [NEEDS-RESEARCH]

Secondary Mechanisms

• Polysaccharide immunomodulation (inferred): Beta-glucan and heteropolysaccharide content, characteristic of the Hymenochaetaceae, likely contributes to innate immune stimulation via Dectin-1 and complement receptor 3 (CR3) pathways. This is well-established for related species but unconfirmed for I. dryadeus specifically. [UNCERTAIN]
• Ergosterol and related sterols: Ergosterol derivatives may contribute to overall antioxidant and anti-inflammatory profiles, consistent with other wood-decomposing fungi.

Clinical Evidence Summary

No human clinical trials, animal studies, or case reports have been published for Inonotus dryadeus. The sole pharmacological study is a mycochemical investigation with in vitro antioxidant assays.

Key Preclinical Studies

Evidence Limitations

• Only one published pharmacological study exists for this species.
• No animal models or human studies have been conducted.
• The hispidin content has been identified by chemical analysis but has not been quantified relative to other Inonotus species (particularly chaga).
• Antimicrobial claims are based on preliminary reports without detailed methodology published in the indexed literature accessible to this review.
• The species is not commercially available as a supplement, limiting practical relevance.
• Taxonomic uncertainty: The transfer to Pseudoinonotus dryadeus by Wagner & Fischer (2001) is accepted by some authorities but not universally. Literature may use either Inonotus dryadeus or Pseudoinonotus dryadeus, potentially causing confusion in literature searches.
• Most pharmacological inferences are extrapolated from related species (particularly I. obliquus, I. hispidus, and Phellinus spp.) rather than direct evidence from I. dryadeus.

Safety Profile

General Assessment

Inonotus dryadeus is not traditionally consumed as food and is generally classified as inedible due to its tough, fibrous texture and bitter taste. No formal safety or toxicological assessments have been conducted. The species is primarily recognized as a tree pathogen rather than a medicinal or edible fungus.

Contraindications

• Not established as edible or safe for consumption. Do not consume without expert mycological guidance.
• Pregnancy and lactation: Insufficient safety data.
• Known allergy to polypore fungi: Individuals with sensitivity to bracket fungi should avoid exposure.

Drug Interactions

• No data available. No drug interactions have been studied or reported.

Side Effects

• No data available. The species is not consumed in any traditional or modern context, so no side effect profile has been established.

Toxicology

• No toxicological studies have been published.
• Heavy metal accumulation: As a wood-decomposing fungus parasitic on oaks, I. dryadeus may accumulate heavy metals from contaminated urban or industrial-site trees. This is a general concern for all wild-harvested polypores.
• No known acute toxins have been identified, but the absence of toxicity data should not be interpreted as evidence of safety.

Clinical Dosage

No Established Dosage

No dosage recommendations exist for Inonotus dryadeus in any traditional or modern context. The species is not commercially available as a supplement or medicinal preparation.

Research Context

• The mycochemical study by Angelini et al. (2015) used methanol extraction of dried fruiting body material for chemical analysis and in vitro assays. No dosage translation to human use has been attempted.

Form Selection Guidance

There are no commercially available forms. Any future development of I. dryadeus as a source of hispidin-class antioxidants would require systematic bioactivity-guided fractionation, safety assessment, and dose-finding studies.

Sources

• Angelini P, Girometta C, Tirillini B, et al. Antioxidant properties of oak bracket mushroom, Pseudoinonotus dryadeus (higher Basidiomycetes): a mycochemical study. Int J Med Mushrooms. 2015;17(11):1047-1058
• Wagner T, Fischer M. Natural groups and a revised system for the European poroid Hymenochaetales (Basidiomycota) supported by nrDNA sequence data. Mycol Res. 2001;105(7):773-782
• Lee IK, Yun BS. Styrylpyrone-class compounds from medicinal fungi Phellinus and Inonotus spp., and their medicinal importance. J Antibiot. 2011;64(5):349-359
• Jung JY, Lee IK, Seok SJ, et al. Antioxidant hispidin derivatives from medicinal mushroom Inonotus hispidus. Chem Pharm Bull. 2008;56(3):297-300
• Olennikov DN, Tankhaeva LM, Rokhin AV, et al. Styrylpyrone glycosides from mycelium of Inonotus rheades. Chem Nat Compd. 2023;59(6):1056-1062
• First Nature. Pseudoinonotus dryadeus, Oak Bracket fungus. Available at: first-nature.com
• Zombiemyco. Oak Bracket Fungus (Inonotus dryadeus). Available at: zombiemyco.com

Connections

• Chaga comparison: I. dryadeus is a congener of Chaga (Inonotus obliquus), the most commercially important medicinal Inonotus species. Both produce hispidin and styrylpyrone pigments, but chaga has vastly more extensive research, including human clinical data. The chemical kinship suggests that I. dryadeus may share some of chaga’s pharmacological potential, but this remains unproven.
• Inonotus hispidus parallel: Inonotus hispidus (shaggy bracket) is another tree-parasitic Inonotus with confirmed hispidin content and more developed antioxidant research. Like I. dryadeus, it is not traditionally consumed but has attracted interest for its styrylpyrone chemistry.
• Hymenochaetaceae medicinal network: I. dryadeus belongs to the same family as Phellinus linteus (meshima) and Sanghuangporus sanghuang, both of which are well-established medicinal polypores in East Asian traditions. The shared styrylpyrone biosynthetic capacity across this family suggests a conserved pharmacological theme that merits further investigation in less-studied species like I. dryadeus.
• Antioxidant bracket fungi: The antioxidant profile of I. dryadeus parallels that of Fomes fomentarius (tinder fungus) and other perennial polypores, though the specific chemical classes differ (styrylpyrones vs. triterpenoids and melanins).